The Procter & Gamble Company (NYSE:PG) Shares Sold by Deseret Mutual Benefit Administrators

Deseret Mutual Benefit Administrators lowered its position in shares of The Procter & Gamble Company (NYSE:PG) by 3.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,578 shares of the company’s stock after selling 391 shares during the quarter. Procter & Gamble accounts for approximately 0.8% of Deseret Mutual Benefit Administrators’ investment portfolio, making the stock its 19th largest position. Deseret Mutual Benefit Administrators’ holdings in Procter & Gamble were worth $1,659,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. China Universal Asset Management Co. Ltd. grew its position in Procter & Gamble by 5.5% in the first quarter. China Universal Asset Management Co. Ltd. now owns 32,001 shares of the company’s stock worth $5,192,000 after buying an additional 1,657 shares during the last quarter. Quent Capital LLC boosted its stake in shares of Procter & Gamble by 2.0% during the 1st quarter. Quent Capital LLC now owns 10,684 shares of the company’s stock worth $1,733,000 after acquiring an additional 206 shares in the last quarter. Comprehensive Financial Consultants Institutional Inc. increased its stake in Procter & Gamble by 6.2% in the 1st quarter. Comprehensive Financial Consultants Institutional Inc. now owns 9,383 shares of the company’s stock worth $1,522,000 after purchasing an additional 550 shares in the last quarter. Proficio Capital Partners LLC raised its holdings in shares of Procter & Gamble by 2.5% during the first quarter. Proficio Capital Partners LLC now owns 9,287 shares of the company’s stock valued at $1,507,000 after acquiring an additional 228 shares during the period. Finally, Pictet North America Advisors SA raised its stake in Procter & Gamble by 12.7% during the 1st quarter. Pictet North America Advisors SA now owns 21,533 shares of the company’s stock valued at $3,494,000 after purchasing an additional 2,422 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

NYSE:PG opened at $161.19 on Thursday. The firm has a market capitalization of $379.61 billion, a PE ratio of 27.76, a PEG ratio of 3.57 and a beta of 0.42. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The firm’s fifty day simple moving average is $171.29 and its 200 day simple moving average is $168.13.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the previous year, the company posted $1.83 earnings per share. The firm’s revenue for the quarter was down .6% on a year-over-year basis. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.50%. Procter & Gamble’s payout ratio is 69.48%.

Insider Buying and Selling

In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the sale, the chief executive officer now owns 263,537 shares in the company, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 385,771 shares of company stock valued at $65,610,975. 0.18% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on PG shares. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research note on Monday, September 30th. Citigroup raised their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Piper Sandler assumed coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Finally, Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price target for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.